InsidersTradesSigma
Track the ADC Therapeutics SA stock price and the full directors' dealings record of the company, a listed issuer based in United States. Shares are quoted on the US market, under the oversight of SEC (Form 4). Market capitalisation: €128.9m. The latest transaction was filed on 2 July 2026 (Attribution). Among the most active insiders: Redmile Group, LLC. The full history is openly available.
78
Insider Decl.
n/a
Thresholds
€1m
2 ops.
Buy Volume
€17m
15 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate ADC Therapeutics SA Buy (bullish), based on 3 analysts. Average price target: US$3.33.
26Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 2 July 2026
Declarations78 total
675,000 sharesCommon SharesSEC:0001628280-26-047031:0
203,700 sharesCommon SharesSEC:0001628280-26-047033:0
221,100 sharesCommon SharesSEC:0001628280-26-047034:0
213,900 sharesCommon SharesSEC:0001628280-26-047036:0
12,600 shares@ US$3.08100.0% of flowCommon SharesSEC:0001628280-26-040487:1
12,600 shares@ US$3.0836.7% of flowCommon SharesSEC:0001628280-26-040488:1
2,596 shares@ US$3.0836.8% of flowCommon SharesSEC:0001628280-26-040490:1
15,196 shares@ US$3.0838.0% of flowCommon SharesSEC:0001628280-26-040492:1
12,600 shares@ US$3.0836.7% of flowCommon SharesSEC:0001628280-26-040493:1
45,000 shares0Common SharesSEC:0001628280-26-040487:0
45,000 shares0Common SharesSEC:0001628280-26-040488:0
45,000 shares0Common SharesSEC:0001628280-26-040490:0
45,000 shares0Common SharesSEC:0001628280-26-040491:0
45,000 shares0Common SharesSEC:0001628280-26-040492:0
45,000 shares0Common SharesSEC:0001628280-26-040493:0
12,600 shares@ US$3.0836.7% of flowCommon SharesSEC:0001628280-26-040491:1
196,229 shares@ US$3.7523.5% of flowCommon StockSEC:0001104659-26-039359:0
188,407 shares@ US$3.7523.4% of flowCommon StockSEC:0001104659-26-039359:1
169,265 shares@ US$3.7993.0% of flowCommon StockSEC:0001104659-26-039359:2
162,517 shares@ US$3.7992.9% of flowCommon StockSEC:0001104659-26-039359:3
2,634,506 shares@ US$3.27941.1% of flowCommon StockSEC:0001104659-26-039359:4
2,529,491 shares@ US$3.27939.5% of flowCommon StockSEC:0001104659-26-039359:5
62,900 shares@ US$3.9967.0% of flowCommon SharesSEC:0001628280-26-009283:0
25 of 78 declarations
Acerca de ADC Therapeutics SA
ADC Therapeutics SA es una empresa biofarmacéutica centrada en el desarrollo de terapias dirigidas para el tratamiento del cáncer. Se especializa en conjugados anticuerpo-fármaco y tratamientos innovadores para mejorar los resultados de los pacientes.